MML INVESTORS SERVICES, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 701059
SPRINGFIELD, MA
Position in ALNY
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$5,122,529
-$1,895,993 QoQ
Shares Held
15,482
-12.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MML INVESTORS SERVICES, LLC holds $68,664,661 across 56 Biotechnology names. ALNY ranks #3 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,419 | $14,922,920 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,009 | $13,141,833 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
15,482 | $5,122,529 | |
| 4 | ARGX |
Argenx SE
|
6,011 | $4,389,532 | |
| 5 | INSM |
INSMED Inc
|
24,773 | $4,050,880 | |
| 6 | RPRX |
Royalty Pharma plc
|
42,269 | $2,027,643 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
|
58,950 | $1,964,214 | |
| 8 | EXEL |
Exelixis, Inc.
|
40,961 | $1,756,817 |
All Filings in ALNY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,122,529 | 15,482 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $7,018,522 | 17,650 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,973,168 | 19,678 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,816,793 | 17,838 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,490,548 | 12,927 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,526,758 | 10,738 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $848,742 | 3,086 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $709,560 | 2,920 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $623,057 | 4,169 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $756,452 | 3,952 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $532,185 | 3,005 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $620,344 | 3,266 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $533,251 | 2,662 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $573,211 | 2,412 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $353,682 | 1,767 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,446,102 | 9,915 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,512,228 | 9,261 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,533,511 | 9,043 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,553,717 | 8,229 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,299,709 | 7,667 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,020,380 | 7,227 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||